PEDIATRICS Vol. 34 No. 4 October 1964, pp. 585
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ABLER, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ABLER, C.

Sulfadiazine-Resistant Meningococcus

CHARLES ABLER M.D.1

1 Meningitis Division, New York City Department of Health

Lest some unwarranted doubts may arise regarding the therapeutic efficacy of sulfadiazine in the treatment of meningococcal infections (excluding the fulminans type) or the emergence recently of resistant strains, from the article "Meningococcal Disease Due to a Sulfadiazine Resistant Strain" which appeared in Pediatrics, 34:124 (1964), I hasten to point out that both in this article and the reference that it draws upon heavily (J.A.M.A., 186:139, 1963), the only warranted deduction from the data detailed is that Group B meningocci are relatively more resistant or less sensitive to sulfadiazine compared to Group C meningococci on testing in vitro.